This company is focused on conquering the global brain disease crisis by using state-of-the-art neural network technologies to create Data Biopsy Signatures™ that map disease mechanisms to Precision Phenotypes™. They aim to develop targeted treatments by matching the right therapeutic to the right patient populations. Their goal is to create a new era in modern precision medicine.